ASTRAZENECA has struck a deal worth up to $400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease.
»
AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical
![AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical]()
Reviewed by Unknown
on
30 August
Rating:
No comments:
Post a Comment